ArticleOncotarget2016

Technetium-99m-labeled rituximab for use as a specific tracer of sentinel lymph node biopsy: a translational research study.

Xuejuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.